A public health care provider in Israel says 0.01% of people who received two doses of coronavirus vaccine have tested positive for the virus.
Maccabi Healthcare Services is in charge of a program that uses the vaccine developed by Pfizer and its partner BioNTech. On Monday it published the preliminary results of a survey of 128,600 people who received two doses.
Maccabi says 20 of the recipients became infected with the virus a week after receiving the second shots.
Maccabi says the 20 developed symptoms such as coughing and headaches, but that none were hospitalized.
He adds that ten of them suffer from underlying conditions.
Maccabi says the data is preliminary but very encouraging.
Israel leads the world in making vaccines quickly. On Tuesday, 2.7 million people, or more than 30 percent of the country’s population, had received the first shots and about 1.4 million had received the second.
Israel has reported that more than 600,000 of its nine million people have been infected with the virus. The third blockade of the country is in force until the end of this month.
Israel began inoculating health workers and people 60 and older on December 19th. The government plans to complete vaccinations for all over-16s by the end of March.